Stockscreener 앱 받기
4.58
8.03%
-0.40
Foghorn Therapeutics Inc 주식(FHTX)의 최신 뉴스
Published on: 2025-08-10 22:12:46 - Newser
Using data filters to optimize entry into Foghorn Therapeutics Inc.Trading Opportunities Forecast by AI Insight - Newser
Foghorn Therapeutics Inc.’s volatility index tracking explainedFree Watchlist for Low Risk High Return - Newser
Can technical indicators confirm Foghorn Therapeutics Inc.’s reversalStock Market Watch with Smart Filters - Newser
Research Analysts Offer Predictions for FHTX Q3 Earnings - Defense World
Applying Wyckoff theory to Foghorn Therapeutics Inc. stockIntraday Signal Forecast for Fast Traders - Newser
Understanding Foghorn Therapeutics Inc.’s price movementWeekly Hot Stocks Based on Volume Flow - Newser
Will Foghorn Therapeutics Inc. bounce back from current supportAI Driven Swing Trade Forecasting Insight - Newser
Sentiment analysis tools applied to Foghorn Therapeutics Inc.Entry Optimization Guide with Volume Analysis - Newser
Real time alert setup for Foghorn Therapeutics Inc. performanceShort-Term Bounce Forecast for Oversold Stocks - Newser
Top Risks to Consider Before Buying Foghorn Therapeutics Inc. StockChart Scanner for Swing Trade Timing - Newser
What high frequency data says about Foghorn Therapeutics Inc.Free Entry Alert With Low Drawdown Strategy - Newser
How to escape a deep drawdown in Foghorn Therapeutics Inc.Technical Reversal Pattern Summary and Tracker - Newser
Can volume confirm reversal in Foghorn Therapeutics Inc.Value Holding Return Summary With Outlook - Newser
Leading vs lagging indicators on Foghorn Therapeutics Inc. performanceSecure Entry Point Finder with Analysis - Newser
Using portfolio simulators with Foghorn Therapeutics Inc. includedPredictive AI Engine for Smart Investing - Newser
Published on: 2025-08-09 01:18:22 - Newser
How Foghorn Therapeutics Inc. stock performs during market volatilitySteady Return Plan Based on Data Analysis - Newser
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing - Yahoo Finance
Is Foghorn Therapeutics Inc. stock ready for a breakoutLow Volatility Stock Analysis With Confidence - Newser
Wedbush Research Analysts Boost Earnings Estimates for FHTX - Defense World
How to recover losses in Foghorn Therapeutics Inc. stockSafe Entry Screening with Data Backed Analysis - Newser
Foghorn Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayHigh Conviction Stock Long-Term Summary - Newser
Is Foghorn Therapeutics Inc. trending in predictive chart modelsFree Community Strategy With High Win Rate - Newser
Q1 Earnings Estimate for FHTX Issued By Wedbush - Defense World
Foghorn Therapeutics (FHTX) Expected to Announce Earnings on Thursday - Defense World
Foghorn Therapeutics Inc. stock prediction for this weekLong Term Stock Growth Plan Suggestions - Newser
Foghorn 2025 Q2 Earnings Narrowed Losses, 21.9% Net Income Improvement - AInvest
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Foghorn Therapeutics Reports Q2 2025 Financial Results - TipRanks
Is Foghorn Therapeutics Inc. meeting your algorithmic filter criteriaDaily Technical Forecast for Quick Gains - Newser
Foghorn Therapeutics Inc (FHTX) Q2 2025 Earnings: EPS of -$0.33 - GuruFocus
Foghorn Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2025 - MarketScreener
Foghorn Therapeutics Reports Q2 2025 Financial Update - TipRanks
FHTX Reports Strong Q2 Revenue and Advances Cancer Treatment Pip - GuruFocus
Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Invest In Growth? - uk.finance.yahoo.com
Foghorn Therapeutics Inc. SEC 10-Q Report - TradingView
Foghorn Therapeutics Q2 collaboration revenue rises, loss narrows - MarketScreener
Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update - The Manila Times
Foghorn Reports Major Progress in Lung Cancer Drug Trial, Multiple Pipeline Developments Advance - Stock Titan
0.24%
3.39%
자본화:
|
볼륨(24시간):